Risk factors for development of hemolytic uremic syndrome during shigellosis.
Butler
T
T
Islam
M R
MR
Azad
M A
MA
Jones
P K
PK
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001459:Bangladesh; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D012189:Retrospective Studies; D012306:Risk; D012762:Shigella dysenteriae / Q000302:isolation & purification
D000900:Anti-Bacterial Agents